3 High-Growth TSX Stocks Available at Deep Discount

These three high-growth TSX stocks look attractively after the recent pullback.

| More on:

Amid the encouraging announcements on the vaccine, the high-growth TSX stocks, which had witnessed strong growth this year, have experienced some pressure. The shift in investors’ focus toward value stocks, steep valuations, and the expectation of a decline in the demand for their services with life and business returning to pre-pandemic ways have led to a fall in their stock prices.

Meanwhile, I believe the long-term growth prospects of these three TSX companies are still intact. The corrections would be a good opportunity for investors with three years horizon to accumulate these stocks for greater returns.

Real Matters

Real Matters (TSX:REAL), which services mortgage lenders and insurance companies, has been under pressure in recent times due to its weak fourth-quarter performance and a pullback in high-growth stocks. Currently, it trades over 42% discount from its 52-week high.

In the fourth quarter, Real Matters reported an adjusted EPS of $0.18, missing analysts’ expectations of $0.19 per share. Further, its sales growth slowed down to 36.7% compared to 52.7% in the third quarter. During the quarter, the refinance volumes declined by 9% due to the reduction of addressable market volumes, as an increased number of customers used waivers for refinance transactions amid the pandemic.

Meanwhile, the company has set an optimistic 2025 outlook. The management hopes to expand its purchase market share and refinance market share in the United States Appraisal segment to 7-9% and 17-19%, respectively. Meanwhile, the refinancing market share in the Title segment could increase to 6-8%.

Further, amid the recent pullback, its valuation has fallen to attractive levels. Currently, Real Matters trades at a forward price-to-earnings multiple of 20.1 and a forward enterprise value-to-sales multiple of 2.1.

Kinross Gold

The gold prices have cooled down due to the encouraging data on the vaccine, leading to a healthy correction in gold mining companies, including Kinross Gold (TSX:K)(NYSE:KGC). Amid the recent decline, Kinross Gold trades at over a 30% discount from its 52-week high of $13.59.

In its recently announced third quarter, its top-line grew by 29%, driven by higher average realized gold price partially offset by lower production volumes. Meanwhile, its adjusted EPS increased by 212.5% due to higher realized gold prices and a decline in its capital expenditure.

Meanwhile, the company’s management has planned to raise its production over the next three years, while its production and capital expenditure could go down. So, given its higher production and lower expenses, I am bullish on Kinross Gold. Besides, the company has announced quarterly dividends of $0.03 per share. So, its dividend yield currently stands at 1.3%.

Kinaxis

My third pick would be Kinaxis (TSX:KXS), which provides cloud-based software solutions to aid supply chain companies in better decision making. Amid the globalization and growth in e-commerce, the demand for the company’s services has increased, driving its financials and stock price.

The company’s top-line increased by 17% in its third quarter, driven by growth in its SaaS and professional services segment.

However, its adjusted EBITDA margin contracted from 26% to 18% due to its recent acquisitions and business investments. Meanwhile, the company’s management hiked its sales guidance for fiscal 2020.

Amid the structural shift toward online shopping, e-commerce sales are expanding, which could benefit Kinaxis. Further, the company has acquired Rubikloud, which provides artificial intelligence-based solutions to CPG companies. It is also focusing on developing innovative products to expand its customer base. So, the company’s growth prospects look healthy.

Amid the recent pullback, Kinaxis is trading 17.5% lower to its 52-week high, which provides an excellent buying opportunity for long-term investors.

The Motley Fool recommends KINAXIS INC and Real Matters Inc. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Tech Stocks

Quantum Computing Words on Digital Circuitry
Tech Stocks

Investors: Canada’s Government Is Backing Quantum Computing

Here’s what the Canadian government’s major new investment in quantum computing means for investors.

Read more »

top TSX stocks to buy
Tech Stocks

As the TSX Breaks Higher, These Canadian Stocks Look Poised to Win in 2026

Three Canadian stocks with high-velocity growth potential could be among TSX’s winning investments in 2026.

Read more »

warehouse worker takes inventory in storage room
Tech Stocks

Outlook for Shopify Stock in 2026

Shopify has delivered another strong year, but the bigger question now is whether its expanding platform and AI push can…

Read more »

AI concept person in profile
Tech Stocks

TFSA Wealth Plan: Create $1 Million With a Single Canadian Stock

Topicus could help build a $1 million TFSA thanks to sticky software, recurring revenue, and a disciplined acquisition engine if…

Read more »

AI image of a face with chips
Tech Stocks

The Market Sold BlackBerry After Its Earnings Beat – Here’s Why I’d Buy More

BlackBerry (TSX:BB) beat expectations again, yet the stock slipped, and a closer look at its latest numbers shows why that…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

These 2 TSX Stocks Look Set to Soar in 2026 and Beyond

2 TSX stocks to buy for 2026: MDA Space (MDA) offers deep value with a massive backlog, while Descartes Systems…

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Tech Stocks

1 Dividend-Paying Tech Stock I’d Buy Before Touching Shopify

Constellation Software (TSX:CSU) might be a better value than other Canadian tech stars in 2026.

Read more »

doctor uses telehealth
Tech Stocks

Ready for Healthcare AI? Put WELL Health Technologies Plus 2 More on Your Watchlist

Three Canadian companies are sound investment options as AI adoption in the healthcare sector accelerates.

Read more »